Among HCC patients exhibiting AFP levels below 200 ng/mL, SNHG18 shows comparatively high sensitivity and specificity relative to cirrhosis patients and healthy controls, with sensitivity at 75.61% and specificity at 73.49% [122]. The gene discussed is AFP; the disease is hepatocellular carcinoma.